Annals
Established in 1927 by the American College of Physicians
:
Advanced search
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article
space
 arrow  PDF of this article
(PDFs free after 6 months)
space
 arrow  Summary for Patients
space
 arrow  Figures/Tables List
space
 arrow  Related articles in Annals
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Prasad, A. S.
space
  arrow  Chandrasekar, P. H.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

ARTICLE

Duration of Symptoms and Plasma Cytokine Levels in Patients with the Common Cold Treated with Zinc Acetate

A Randomized, Double-Blind, Placebo-Controlled Trial

right arrow Ananda S. Prasad, MD, PhD; James T. Fitzgerald, PhD; Bin Bao, MD, PhD; Frances W.J. Beck, PhD; and Pranatharthi H. Chandrasekar, MD

15 August 2000 | Volume 133 Issue 4 | Pages 245-252

Background: Adults and children in the United States get two to six colds per year. Evidence that zinc is effective therapy for colds is inconsistent.

Objective: To test the efficacy of zinc acetate lozenges in reducing the duration of symptoms of the common cold.

Design: Randomized, double-blind, placebo-controlled trial.

Setting: Detroit Medical Center, Detroit, Michigan.

Patients: 50 ambulatory volunteers recruited within 24 hours of developing symptoms of the common cold.

Intervention: Participants took one lozenge containing 12.8 mg of zinc acetate or placebo every 2 to 3 hours while awake as long as they had cold symptoms.

Measurements: Subjective symptom scores for sore throat, nasal discharge, nasal congestion, sneezing, cough, scratchy throat, hoarseness, muscle ache, fever, and headache were recorded daily for 12 days. Plasma zinc and proinflammatory cytokine levels were measured on day 1 and after participants were well.

Results: Forty-eight participants completed the study (25 in the zinc group and 23 in the placebo group). Compared with the placebo group, the zinc group had shorter mean overall duration of cold symptoms (4.5 vs. 8.1 days), cough (3.1 [95% CI, 2.1 to 4.1] vs. 6.3 [CI, 4.9 to 7.7] days), and nasal discharge (4.1 [CI, 3.3 to 4.9] vs. 5.8 [CI, 4.3 to 7.3] days) and decreased total severity scores for all symptoms (P < 0.002, test for treatment x time interaction). Mean changes in soluble interleukin-1 receptor antagonist level differed nonsignificantly between the zinc group and the placebo group (difference between changes, –89.4 pg/mL [CI, –243.6 to –64.8 pg/mL]).

Conclusion: Administration of zinc lozenges was associated with reduced duration and severity of cold symptoms, especially cough. Improvement in clinical symptoms with zinc treatment may be related to a decrease in proinflammatory cytokine levels; however, in this study, the observed differences between changes in cytokine levels in zinc and placebo recipients were not significant.

Author and Article Information
space

From Wayne State University School of Medicine, Detroit, Michigan; and University of Michigan Medical School, Ann Arbor, Michigan.

Acknowledgments: The authors thank Diane Snell, Karen Mirisola, James Nowak, and Sally Bates for technical and secretarial assistance.

Grant Support: In part by an unrestricted fund from the George and Patsy Eby Research Foundation.

Requests for Single Reprints: Ananda S. Prasad, MD, PhD, Department of Medicine, Division of Hematology-Oncology, Wayne State University, University Health Center 5-C, 4201 St. Antoine, Detroit, MI 48201.

Requests To Purchase Bulk Reprints (minimum, 100 copies): the Reprints Coordinator; phone, 215-351-2657; e-mail, reprints{at}mail.acponline.org.

Current Author Addresses: Drs. Prasad, Bao, and Beck: Department of Medicine, Division of Hematology-Oncology, Wayne State University, University Health Center, 5-C, 4201 St. Antoine, Detroit, MI 48201.

Dr. Fitzgerald: Department of Medical Education, University of Michigan, G-1100 Towsley Center 0201, Ann Arbor, MI 40109-0201.

Dr. Chandrasekar: Division of Infectious Diseases, Department of Medicine, Wayne State University, Harper Hospital, 4-Yellow Center, 3990 John R., Detroit, MI 48201.

Author Contributions: Conception and design: A.S. Prasad, P.H. Chandrasekar.

Analysis and interpretation of the data: A.S. Prasad, J.T. Fitzgerald, B. Bao, F.W.J. Beck.

Drafting of the article: A.S. Prasad, J.T. Fitzgerald.

Critical revision of the article for important intellectual content: A.S. Prasad.

Final approval of the article: A.S. Prasad, P.H. Chandrasekar.

Provision of study materials or patients: A.S. Prasad, P.H. Chandrasekar.

Statistical expertise: J.T. Fitzgerald.

Obtaining of funding: A.S. Prasad.

Administrative, technical, or logistic support: A.S. Prasad, F.W.J. Beck.

Collection and assembly of data: J.T. Fitzgerald, B. Bao, F.W.J. Beck.


Related articles in Annals:

Summaries for Patients
Zinc Acetate Lozenges To Treat the Common Cold
Annals 2000 133: 245. [Full Text]  

Editorials
Lessons Learned from Attempts To Establish the Blind in Placebo-Controlled Trials of Zinc for the Common Cold
Norman A. Desbiens
Annals 2000 133: 302-303. [Full Text]  

Letters
Blinding in Placebo-Controlled Trials
Ananda S. Prasad
Annals 2001 134: 1150. [Full Text]  

Letters
Blinding in Placebo-Controlled Trials
George E. Ehrlich
Annals 2001 134: 1150-1151. [Full Text]  

Letters
Blinding in Placebo-Controlled Trials
Norman A. Desbiens
Annals 2001 134: 1151. [Full Text]  



This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
H. H Sandstead, A. S Prasad, J. G Penland, F. W. Beck, J. Kaplan, N. G Egger, N. W Alcock, R. M Carroll, V. Ramanujam, H. H Dayal, et al.
Zinc deficiency in Mexican American children: influence of zinc and other micronutrients on T cells, cytokines, and antiinflammatory plasma proteins
Am. J. Clinical Nutrition, October 1, 2008; 88(4): 1067 - 1073.
[Abstract] [Full Text] [PDF]


Home page
AAP Grand RoundsHome page
M. Dubik
Zinc Lozenges Ameliorate Cold Symptoms
AAP Grand Rounds, June 1, 2008; 19(6): 64 - 64.
[Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A. S Prasad, F. W. Beck, B. Bao, J. T Fitzgerald, D. C Snell, J. D Steinberg, and L. J Cardozo
Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative stress
Am. J. Clinical Nutrition, March 1, 2007; 85(3): 837 - 844.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D. C. Bolser
Cough Suppressant and Pharmacologic Protussive Therapy: ACCP Evidence-Based Clinical Practice Guidelines
Chest, January 1, 2006; 129(1_suppl): 238S - 249S.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
R. Gonzales
A 65-Year-Old Woman With Acute Cough Illness and an Important Engagement
JAMA, May 28, 2003; 289(20): 2701 - 2708.
[Full Text] [PDF]


Home page
QJMHome page
S.B. Mossad
Effect of zincum gluconicum nasal gel on the duration and symptom severity of the common cold in otherwise healthy adults
QJM, January 1, 2003; 96(1): 35 - 43.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
C. J. Field, I. R. Johnson, and P. D. Schley
Nutrients and their role in host resistance to infection
J. Leukoc. Biol., January 1, 2002; 71(1): 16 - 32.
[Abstract] [Full Text] [PDF]


Home page
Evid. Based Med.Home page
P. Little
Zinc acetate lozenges reduced the duration and severity of symptoms of the common cold
Evid. Based Med., March 1, 2001; 6(2): 46 - 46.
[Full Text]


Home page
NEJMHome page
R. S. Irwin and J. M. Madison
The Diagnosis and Treatment of Cough
N. Engl. J. Med., December 7, 2000; 343(23): 1715 - 1721.
[Full Text] [PDF]


Home page
Journal Watch DermatologyHome page
Zinc and the Common Cold
Journal Watch Dermatology, November 22, 2000; 2000(1122): 9 - 9.
[Full Text]


Home page
JWatch Infect. DiseasesHome page
Zinc and the Common Cold
Journal Watch Infectious Diseases, October 19, 2000; 2000(1019): 9 - 9.
[Full Text]


Home page
JWatch Emergency Med.Home page
Zinc Reduces Duration of Cold Symptoms
Journal Watch Emergency Medicine, October 3, 2000; 2000(1003): 5 - 5.
[Full Text]




 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 2000 by the American College of Physicians.